Volume | 21,754 |
|
|||||
News | - | ||||||
Day High | 42.82 | Low High |
|||||
Day Low | 42.74 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Taro Pharmaceutical Industries Ltd | TARO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
42.82 | 42.74 | 42.82 | 42.81 | 42.80 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
608 | 21,754 | US$ 42.78 | US$ 930,718 | - | 32.67 - 45.76 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 4,281 | US$ 42.81 | USD |
Taro Pharmaceutical Industries Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.61B | 37.58M | - | 629.18M | 53.87M | 1.43 | 29.83 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Taro Pharmaceutical Indu... News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 42.69 | 42.86 | 42.62 | 42.75 | 25,983 | 0.12 | 0.28% |
1 Month | 42.55 | 42.86 | 42.40 | 42.71 | 30,609 | 0.26 | 0.61% |
3 Months | 42.32 | 42.86 | 41.85 | 42.43 | 26,816 | 0.49 | 1.16% |
6 Months | 41.32 | 45.76 | 40.45 | 42.23 | 41,249 | 1.49 | 3.61% |
1 Year | 40.31 | 45.76 | 32.67 | 39.91 | 43,535 | 2.50 | 6.20% |
3 Years | 74.30 | 75.14 | 22.89 | 40.72 | 28,308 | -31.49 | -42.38% |
5 Years | 88.99 | 99.69 | 22.89 | 58.55 | 34,000 | -46.18 | -51.89% |
Taro Pharmaceutical Indu... Description
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries. |